JPRN-UMIN000036721已完成4 期
Observation of Coronary Atheroma Progression under Glucose Control with ConTInuous Glucose Monitoring GuidAnce in Patients with Type 2 Diabetes MeLlitus: Near-infrared Spectroscopic Analaysis - OPTIMA
ational Cerebral & Cardiovascular Centre0 个研究点目标入组 94 人开始时间: 2019年5月15日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 94
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The main exclusion criteria are listed in Table 3. Non-culprit vessel with its severe tortuousty and/or calcification will be excluded due to the risk of NIRS/IVUS imaging. Subjects with baseline estimated glomerular filtration rate <40 mL/min/1.73m2, those without any atherosclerotic lesions in their non-culprit vessels and patients who are taking or are scheduled to receive proprotein convertase subxilisin/kexin type 9 will not be eligible.
研究者
相似试验
招募中
4 期
Coronary Atheroma Progression under Glucose Control with ConTInuous Glucose MonitoringCoronary artery disease in patients with type 2 diabetes mellitusCoronary artery disease, atherosclerosis, type 2 diabetes mellitus, intravascular imagingJPRN-jRCT1052180152Kataoka Yu90
招募中
不适用
Progression of Subclinical Coronary Atherosclerosis Detected by Coronary Calcium Score Among Virally Suppressed HIV-infected Aging Asians Compared with HIV-Negative IndividualsProgression of Subclinical Coronary Atherosclerosis Detected by Coronary Calcium Score Among Virally Suppressed HIV-infected Aging Asians Compared with HIV-Negative IndividualsHIV, Coronary Atherosclerosis, Coronary Calcium Score, AgingTCTR20221004009Faculty of Medicine320
招募中
不适用
Observational study for coronary vasoreactivity to exercise in patients with vasospastic anginaVasospastic anginaJPRN-UMIN000029777Tohoku University100
进行中（未招募）
1 期
Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN (SATURN): A 104-week, randomized, double-blind, parallel group, multi-center Phase IIIb study comparing the effects of treatment with rosuvastatin 40mg or atorvastatin 80mg on atherosclerotic disease burden as measured by intravascular ultrasound in patients with coronary artery disease - SATUREUCTR2007-004000-13-FRAstraZeneca AB1,300
进行中（未招募）
1 期
Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN (SATURN): A 104-week, randomized, double-blind, parallel group, multi-center Phase IIIb study comparing the effects of treatment with rosuvastatin 40mg or atorvastatin 80mg on atherosclerotic disease burden as measured by intravascular ultrasound in patients with coronary artery disease - SATURCoronary Atheroma -- The current trial will study patients who have a clinical indication for coronary catheterization and who have coronary artery disease.MedDRA version: 9.1Level: LLTClassification code 10011092Term: Coronary atheromaEUCTR2007-004000-13-BEAstraZeneca AB1,300